Product Information
PROCTOFOAM-HC 1%-1% FOAM is a brand (anda) product labeled by Viatris Specialty LLC, priced at $19.3817 per GM under NDC 00037682210. Its NADAC has been published 607 times since Feb 18, 2015.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is BX.
Strength
100; 100 mg/10g; mg/10g
Manufacturer
Viatris Specialty LLCNDC
00037682210
Classification
Brand (ANDA)
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA086195FDA Approved
Before 1982
TE Code
BX
On Market Since
8/15/2014
Pharmacological Classes
Price Statistics
The NADAC for PROCTOFOAM-HC 1%-1% FOAM has been published 607 times since Feb 18, 2015, and over the history we have for it it has risen 113.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.3817 per GM |
|---|---|
| All-time high | $19.3978 (May 13, 2026) |
| All-time low | $9.0827 (Feb 18, 2015) |
| 52-week high | $19.3978 |
| 52-week low | $18.4615 |
| Median price | $14.3422 |
| Average price | $14.8274 |
| Largest weekly change | +14.5% (Mar 18, 2015) |
| Weeks tracked | 607 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pramoxine hydrochloride hydrocortisone acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pramoxine hydrochloride hydrocortisone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCTOFOAM-HC 1%-1% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for PROCTOFOAM-HC 1%-1% FOAM, manufactured by Viatris Specialty LLC, is $19.3817 per GM (NDC 00037682210), effective Sep 30, 2026.
How has the price of PROCTOFOAM-HC 1%-1% FOAM changed over time?
Over the history we have for it, the NADAC for PROCTOFOAM-HC 1%-1% FOAM has risen 113.4%. It has been tracked across 607 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for PROCTOFOAM-HC 1%-1% FOAM?
Since Feb 18, 2015, the NADAC for PROCTOFOAM-HC 1%-1% FOAM has ranged from a low of $9.0827 (Feb 18, 2015) to a high of $19.3978 (May 13, 2026), with a median of $14.3422 per GM.
Are there cheaper alternatives to PROCTOFOAM-HC 1%-1% FOAM?
No other NADAC-published product currently shares the active ingredient and strength of PROCTOFOAM-HC 1%-1% FOAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROCTOFOAM-HC 1%-1% FOAM?
PROCTOFOAM-HC 1%-1% FOAM (NDC 00037682210) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand (anda) product.